Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

162
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
162
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

1.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
Management of Insomnia01:19

Management of Insomnia

289
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
289
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

295
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
295
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

210
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
210
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

206
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
206

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired attention in pediatric narcolepsy type 1.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Patient-reported experiences of cognitive difficulties and their impact on daily life in narcolepsy type 1.

Frontiers in neurology·2026
Same author

Pediatric SleepNet: A Deep Learning Network for Reliable Pediatric Sleep Staging Across Developmental Stages.

Sleep·2026
Same author

Initial validation of a pediatric cataplexy survey for children and adolescents with narcolepsy type 1.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Idiopathic hypersomnia is a 24-hour disorder.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Development of the pediatric narcolepsy patient-reported outcomes scale (PN-PROs).

Frontiers in sleep·2025
Same journal

Sleep in Women.

Sleep medicine clinics·2026
Same journal

Future Research Direction for Women's Sleep Health.

Sleep medicine clinics·2026
Same journal

Sleep Disturbance and Female Infertility.

Sleep medicine clinics·2026
Same journal

Circadian Disruption Shift Work and Breast Cancer Risk.

Sleep medicine clinics·2026
Same journal

Sleep Duration and Mortality in Women: Effect of Aging and Menopause.

Sleep medicine clinics·2026
Same journal

Update on Restless Legs Syndrome Management during Pregnancy.

Sleep medicine clinics·2026
See all related articles

Related Experiment Video

Updated: Aug 1, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.4K

Narcolepsy and Idiopathic Hypersomnia.

Margaret Blattner1, Kiran Maski2

  • 1Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.

Sleep Medicine Clinics
|April 29, 2023
PubMed
Summary
This summary is machine-generated.

Narcolepsy types 1 and 2 and idiopathic hypersomnia cause excessive sleepiness in children and adolescents. While narcolepsy type 1 has a known cause, the origins of the other conditions remain unknown, and cures are unavailable.

Keywords:
HypersomniaMSLTNarcolepsyPediatric

More Related Videos

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

23.9K
A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.4K

Related Experiment Videos

Last Updated: Aug 1, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.4K
Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

23.9K
A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

5.4K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Pediatric Neurology

Background:

  • Narcolepsy types 1 and 2 and idiopathic hypersomnia are central nervous system disorders causing hypersomnolence.
  • Symptoms include profound daytime sleepiness and excessive sleep need, often beginning in childhood or adolescence.
  • Children may exhibit distinct symptoms compared to adults.

Purpose of the Study:

  • To review the characteristics of narcolepsy types 1 and 2 and idiopathic hypersomnia in pediatric populations.
  • To discuss the known and unknown etiologies of these hypersomnolence disorders.
  • To highlight the limitations of current therapeutic interventions.

Main Methods:

  • Literature review of primary central nervous system disorders of hypersomnolence.
  • Analysis of pediatric symptom presentation in narcolepsy and idiopathic hypersomnia.
  • Examination of etiological factors and treatment efficacy.

Main Results:

  • Narcolepsy type 1 is associated with the loss of orexin neurons, likely immune-mediated.
  • The causes for narcolepsy type 2 and idiopathic hypersomnia are currently unknown.
  • Existing treatments can manage symptoms like daytime sleepiness but do not offer a cure.

Conclusions:

  • Further research is needed to elucidate the causes of narcolepsy type 2 and idiopathic hypersomnia.
  • Understanding pediatric-specific presentations is crucial for accurate diagnosis and management.
  • Development of curative treatments for these debilitating sleep disorders is a significant unmet need.